Exclusive: GMC on track to hit three-year GP revalidation target

The GMC is on track to hit its target of revalidating all GPs who were on its register in December 2012 by the end of March 2016, official statistics suggest.

Close to three quarters (71%) of the 60,002 GPs on the GMC register before revalidation began had successfully undergone the process by the end of September 2015, according to official statistics seen by GPonline.

But around 7,000 GPs - 12% of GPs on the December 2012 register - are no longer subject to revalidation, because they are no longer registered, no longer licensed, or now hold temporary registration.

Excluding these GPs, the GMC has revalidated 81% of the GPs still subject to the revalidation process in the target group.

GP revalidation

The GMC aimed to revalidate all GPs on the 2012 register by April 2016, setting out to get through 20% of doctors in year one of the programme (2013/14), followed by another 40% in year two (2014/15) and then the final 40% in year three (2015/16), the current financial year.

Almost 10,000 GPs – 16% of the GPs included in the target – must still undergo revalidation before April for the GMC to hit its target according to the statistics, which run until the end of September.

This gives the regulator six months, as of these figures, to revalidate this 16%, while its target at this point allowed for 20%, suggesting it is slightly ahead of schedule.

A GMC spokeswoman confirmed that it was on track to get through the majority of GPs by April, but added that it was ‘inevitable’ that some may have their revalidation planned for slightly after this date.

Once all doctors have been revalidated once, they will be provided with the date they will next need to be revalidated by in the second round of the revalidation programme.

GP appraisal

GMC chief executive Niall Dickson said: 'We are pleased with the progress that we are making with revalidation, especially in primary care. More than 60,000 GPs have been revalidated since 2012 and we are on track to complete the majority by next spring. These figures are a testament to doctors and to those who have been supporting them with their appraisal and revalidation over the past three years.

'The process is working well, and we believe the system has strengthened clinical governance although we accept there will be lessons to learn as it is developed. The interim evaluation report from independent researchers, which includes a large-scale survey of doctors, will be published in the spring of next year. This will help everyone involved understand where improvements can be made.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

The proportion of NHS GPs trained in the EEA has stabilised after a steady decline...

GPs split on calls to suspend appraisal for duration of pandemic

GPs split on calls to suspend appraisal for duration of pandemic

Senior GPs are divided over calls for appraisal to be halted for the rest of the...

GP fears rising over covert recording of consultations in pandemic

GP fears rising over covert recording of consultations in pandemic

Fears over patients covertly recording consultations have increased among GPs since...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...